7: Head and Neck Pathology

Head and Neck Pathology

Pathologic disease of the head and neck encompasses a wide spectrum of disorders with associated maxillofacial or systemic involvement. The increasing number of disorders and surgical treatments further challenge our profession, often demanding additional training and continuing education courses.

Several categories of disorders can be identified, which can frequently assist in formulation of a differential diagnosis:

1. Infectious (e.g., bacterial, viral, fungal infections)

2. Traumatic etiology (e.g., irritation fibroma)

3. Neoplastic: epithelial, connective tissue, glandular, lymphatic, osseous, muscle, and vascular tumors, which can be characterized as benign or malignant. Metastatic disease to the head and neck, by definition, is malignant.

4. Immunologically mediated disorders (e.g., rheumatoid arthritis)

5. Side effects of other medical or surgical therapy (e.g., osteoradionecrosis)

6. Cysts of the head and neck (inflammatory and noninflammatory cysts)

7. Pathologic processes related to the regional anatomy (e.g., sialolithiasis)

8. Congenital malformations (cleft lip and palate)

9. Degenerative disorders (osteoarthritis)

10. Iatrogenic (e.g., intraoperative damage to a cranial nerve)

11. Idiopathic (e.g., aphthous ulcers)

12. Vasculitis (e.g., temporal arteritis)

Several of these categories are addressed elsewhere in this book. This chapter illustrates eight teaching cases, representing disorders of infectious, traumatic, neoplastic, anatomic, and idiopathic etiology, that are common in the oral and maxillofacial region. A teaching case discussing the differential diagnosis of a neck mass also is provided. The case that discusses osteoradionecrosis outlines the current controversies and management issues arising from this complex complication of head and neck irradiation. Drug-induced osteonecrosis of the jaws (DIONJ) was discussed in Chapter 2.

Pleomorphic Adenoma


General. The patient is a well-developed and well-nourished, 53-year-old woman in no apparent distress.

Vital signs. Blood pressure is 135/90 mm Hg, heart rate 80 bpm, respirations 16 per minute, and temperature 36.9°C.

Maxillofacial. Examination of the eyes and ears is unremarkable. The tympanic membranes are clear bilaterally. Cranial nerves II to XII are intact, with no weakness of the muscles of mastication (V). There is no sensory deficit in the V1-V3 distributions. Facial mimetic muscles are intact and symmetrical (involvement of the facial or trigeminal nerve would be suggestive of a malignant process).

There is a visible swelling in the right subauricular area that distorts the facial contour (Figure 7-1). Palpation reveals a well-circumscribed, freely moveable, firm, rubbery, 1- to 1.5-cm, nontender mass above the angle of the mandible. (Benign processes are typically slow growing and push, rather than infiltrate, local structures, such as the overlying skin; adjacent structures, such as blood vessels and nerves, are usually not involved). There is no warmth, erythema, ulceration, or induration of the overlying soft tissue (signs of an inflammatory or a malignant process).

Intraoral. The parotid papillae appear noninflamed bilaterally, with expression of clear saliva from Stensen’s duct (purulent drainage from the duct would be indicative of suppurative parotitis). No mucosal ulcerations are present, and there is no intraoral extension of the mass (consistent with a benign process).

Neck. No palpable submandibular or cervical lymphadenopathy (palpable lymph nodes would be indicative of a malignant neoplastic process).


Several imaging modalities may be used for the evaluation of a parotid mass, including ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and sialography. The most commonly used initial studies of choice are CT and MRI.

Histologic confirmation is ideally performed preoperatively by means of fine-needle aspiration (FNA). This is best performed by an experienced cytopathologist and can provide diagnostic information guiding definitive treatment. FNA can have a high false-negative rate; therefore, ultrasonographic or CT guidance can be used to recheck when results are inconclusive. Should the FNA results continue to be inconclusive, the clinician should proceed with definitive surgical resection of the tumor with facial nerve preservation, if possible. It is not necessary to perform an open biopsy of the parotid gland, because 80% of parotid masses are benign; therefore, a parotidectomy is appropriate as a diagnostic and treatment modality. Patients should be prepared preoperatively for the possibility of facial nerve deficit. If the integrity of the nerve is maintained during the procedure, facial nerve function returns.

Sialography can be used to identify sialoliths and ductal obstruction and to differentiate parenchymal from nodal disease. A CT scan can also help differentiate nodal from parenchymal disease and is particularly useful in assessing larger lesions with atypical ultrasonic features. However, it is not as reliable as sialography for identification of ductal pathology. MRI offers excellent visualization of the glandular pathology and tumors. It is often the imaging modality of choice. Neither CT nor MRI can reliably outline the surgical anatomy of the mass relative to cranial nerve VII.

A panoramic radiograph can be used as a surveillance imaging tool to exclude the presence of intraductal or glandular calcifications; however, it is not particularly useful in the evaluation of parotid gland lesions.

For the current patient, a panoramic radiograph confirmed no observable pathology. An MRI scan demonstrated a well-circumscribed mass within the substance of the parotid gland, measuring 1.5 cm in diameter, with no homogeneous enhancement (Figure 7-2). There was no evidence of enlarged intraparotid lymph nodes.

Differential Diagnosis

In the current case, the slow, circumscribed growth, lack of fixation, and absence of cranial nerve involvement or adenopathy associated with the lesion suggest a benign process. In addition, the absence of any erythema, pain, or warmth, together with a normal WBC count, implies a noninfectious/inflammatory process. With a swelling in this region, a differential for proliferative processes includes pleomorphic adenoma, subcutaneous lipoma, Warthin’s tumor, monomorphic adenoma, and malignant salivary gland neoplasms (Box 7-1).


FNA demonstrates a combination of ductal cells, chondromyxoid matrix, and dispersed plasmacytoid and lymphocyte-like myoepithelial cells (classic histology for pleomorphic adenoma), confirming the diagnosis of pleomorphic adenoma.

A pleomorphic adenoma is characterized by a variety of morphologic and histologic patterns. It is considered a true “mixed” tumor, referring to the biphasic proliferation of both ductal epithelial and myoepithelial (mesenchymal) cells. The ductal epithelial cells give rise to glandlike epithelial structures, whereas the myoepithelial cells are responsible for the characteristic pleomorphic extracellular matrix (myxochondroid connective tissue). Within a single tumor there may be cellular, glandular, myxoid, cartilaginous, and even ossified features. This morphologic diversity may be evident only when the lesion is excised and examined in its entirety. Histologically, pleomorphic adenomas may resemble polymorphous, low-grade adenocarcinoma, adenoid cystic carcinoma, basal cell adenoma, or epithelial-myoepithelial carcinoma. The connective tissue lining, or “pseudocapsule,” is an important feature limiting growth but may be incomplete or infiltrated by tumor cells (tumor pseudopodia).

FNA may show various combinations of three elements: ductal cells, chondromyxoid matrix, and myoepithelial cells. An aspirate with more than one of these components, especially when accompanied by the characteristic clinical presentation, makes this a straightforward diagnosis.


Enucleation of a pleomorphic adenoma of the parotid gland is associated with recurrence rates of up to 40%. The treatment of choice is a superficial parotidectomy, which has resulted in low morbidity, with recurrence rates of less than 2% to 3%. An attempt should be made to remove the tumor en bloc while maintaining the integrity of the capsule, with a 5-mm cuff of normal tissue. When the capsule is encountered on the deep aspect, it must be carefully dissected from the facial nerve. Maintaining the capsule is thought to be the key factor in minimizing recurrence. This observation led to the development of extracapsular dissection, in which the tumor and capsule are carefully dissected from the parotid gland. This conservative approach is associated with low rates of morbidity (facial nerve damage and Frey syndrome) and recurrence rates of 2% to 3%. Upon excision, the specimen should be delivered to pathology intact, to allow macroscopic evaluation of the integrity of the capsule. Pleomorphic adenomas of the palate should be excised with a 5-mm margin, including the overlying mucosa and underlying periosteum.

For the current patient, a superficial parotidectomy with cranial nerve VII preservation was performed through a face-lift incision. The tumor was excised with a 5- to 10-mm margin of uninvolved surrounding tissue, with the exception of the deep margin, where the capsule was carefully dissected off of the facial nerve.

The procedure is usually initiated by making a modified Blair incision with a no. 15 scalpel blade. The dissection is taken down to the subdermal plane, and the flap is elevated in the preauricular region. The neck extension is dissected through the platysma, and the great auricular nerve is identified and preserved if possible. The anterior border of the sternocleidomastoid muscle is identified, and the proximal third is dissected. The muscle belly is retracted laterally, and the posterior belly of the digastric muscle identified deep to the sternocleidomastoid muscle. The preauricular portion of the dissection is deepened in the pretragal plane to the extent of the bony-cartilaginous junction of the external auditory meatus. The upper and lower portions of the dissections are then joined, and the root of the facial nerve is identified, approximately 4 mm above the posterior belly of the digastric muscle. A nerve stimulator is used for verification. The roots of the facial nerve are then identified, from the frontal, zygomatic, buccal, marginal mandibular, and cervical aspects. The parenchyma of the parotid is then elevated in a superficial plane over the preserved nerve roots. The parotid gland is mobilized anteriorly to include the pleomorphic adenoma. The external carotid artery is usually identified at the deep aspect and left intact. The specimen is removed en bloc and submitted for pathologic examination. The branches of the facial nerve are usually tested after the surgery.

The wound is thoroughly irrigated, and Jackson-Pratt (JP) drains are placed in a dependent fashion. The skin is closed in a layered fashion consisting of deep 3-0 and 4-0 Vicryl sutures, with particular attention to closure of the superficial musculoaponeurotic system to prevent Frey syndrome. The skin can be closed with nonresorbable 5-0 Prolene sutures, which are usually removed about 1 week after surgery.


Early complications can include facial nerve paralysis, hemorrhage, hematoma, infection, skin flap necrosis, trismus, salivary fistula, sialocele, and seroma formation. Long-term complications include Frey syndrome, hypoesthesia of the greater auricular nerve, tumor recurrence, and cosmetic deformity from the soft tissue defect (Box 7-2).

Box 7-2

Complications of Parotidectomy for Pleomorphic Adenoma

• Facial nerve injury. Cranial nerve VII can be preserved in most parotidectomies in the setting of benign disease. However, despite correct surgical technique, paresis of this nerve can occur. Careful handling, with minimal skeletonization of the branches, can help reduce anoxia and ischemia intraoperatively. If major trauma to the nerve is avoided, deficits are usually transient (seen in 14% to 40% of cases) and can be expected to resolve.

• Recurrence. In a review of 52 studies (804 cases of pleomorphic adenoma), Hickman and co-workers reported a 5-year recurrence-free rate of 96.6% and a 10-year recurrence-free rate of 93.7%. There is a higher risk of multifocal recurrence (20% to 40% of cases), of which 25% are malignant, when the surrounding tissues are seeded by inappropriate handling of the tumor, such as with open biopsy of major glands or attempts at enucleation. Such recurrences usually occur within the first 10 years after the original surgery. Some recent immunohistochemical studies (Bankamp and Bierhoff, 1999) have claimed that recurrent tumors are characterized by differentiation of the epithelial components, which is related to greater proliferation.

• Malignancy and metastasis. The overall rate of malignant transformation for a pleomorphic adenoma has been estimated at about 6%. There are three distinct histologic types of mixed tumor with the potential for metastasis:

• Frey syndrome (auriculotemporal nerve syndrome or gustatory sweating). This is a relatively common long-term complication of parotidectomy. It is characterized by localized sweating and dermal flushing during salivary stimulation. This is thought to be caused by aberrant connections between severed secretomotor parasympathetic fibers as they anastomose with severed postganglionic sympathetic fibers that supply the sweat glands of the face in the auriculotemporal region. Frey syndrome has been reported in as many as 30% to 60% of patients undergoing parotidectomy. However, only 10% of patients have symptoms requiring treatment. Treatment options include surgical disruption of the aberrant neural connections or use of botulinum toxin.

From Bankamp DG, Bierhoff E: Proliferative activity in recurrent and nonrecurrent pleomorphic adenoma of the salivary glands, Laryngorhinootologie 78(2):77-80, 1999.


Salivary gland tumors are rare, with an annual overall incidence of 2.5 to 3 per 100,000 population. The majority of parotid (80%) and submandibular gland (60%) tumors are benign. Fifty percent of tumors originating from the minor salivary glands, but only 10% of tumors of the sublingual gland, are benign. Pleomorphic adenoma compromises about 40% to 70% of all salivary gland tumors. It is the most frequent salivary gland tumor in both children and adults and the most common tumor of both major and minor salivary glands. Approximately 75% of pleomorphic adenomas occur in the parotid gland. Ten percent are found in the submandibular gland, and another 10% are found in the palate. Pleomorphic adenomas make up 60% to 70% of all parotid neoplasms, 40% to 60% of submandibular gland tumors, and 40% to 70% of minor salivary gland tumors.

A pleomorphic adenoma classically presents as a painless, firm swelling. It may be lobulated, irregularly dome shaped, or smooth. The consistency is typically rubbery or semisolid, and there may be isolated areas that are softer. If untreated, it enlarges slowly over months or years. The connective tissue capsule generally limits growth, but tumors can become very large if neglected.

In the parotid gland, pleomorphic adenoma most commonly presents in the inferior aspect of the superficial lobe. Deep lobe invasion may manifest as a mass of the soft palate or lateral pharyngeal space. CT or MRI scans can help localize tumor or differentiate lymph nodes from tumor.

The most common intraoral sites are the palate and upper lip. When arising from minor glands of the palate, pleomorphic adenomas are most commonly located lateral to the midline at the junction of the hard and soft palate. Minor gland tumors may cause localized pressure resorption of the palate but do not tend to invade the underlying bone.

Histopathologically, permanent hematoxylin- and eosin–stained sections demonstrate typical histology, including glandlike epithelial cells forming nests, chords, and ductlike structures within a heterogeneous stromal background of myxoid, chondroid, and mucoid material, along with a distinct fibrous connective tissue lining (Figure 7-3).


Allison, GR, Rappoport, I. Prevention of Frey’s syndrome with superficial musculoaponeurotic system interposition. Am J Surg. 1993; 166:407–410.

Bankamp, DG, Bierhoff, E. Proliferative activity in recurrent and nonrecurrent pleomorphic adenoma of the salivary glands. Laryngorhinootologie. 1999; 78(2):77–80.

Garcia-Perla, A, Munoz-Ramos, M, Infante-Cossio, P, et al. Pleomorphic adenoma of the parotid in childhood. J Craniomaxillofac Surg. 2002; 30:242–245.

Hickman, RE, Cawson, RA, Duffy, SW. The prognosis of specific types of salivary gland tumors. Cancer. 1984; 54(8):1620–1624.

Howlett, DC, Kesse, KW, Hughes, DV, et al. The role of imaging in the evaluation of parotid disease. Clin Radiol. 2002; 57:692–701.

Jorge, J, Pires, FR, Alves, FA, et al. Juvenile intraoral pleomorphic adenoma: report of five cases and review of the literature. Int J Oral Maxillofac Surg. 2002; 31:273–275.

Kwon, MY, Gu, M. True malignant mixed tumor (carcinosarcoma) of parotid gland with unusual mesenchymal component: a case report and review of the literature. Arch Pathol Lab Med. 2001; 125:812–815.

Nadershah, M, Salama, A. Removal of parotid, submandibular, and sublingual glands. Oral Maxillofacial Surg Clin North Am. 2012; 24(2):295–305.

Salama, AR, Ord, RA. Clinical implications of neck in salivary gland disease. Oral Maxillofacial Surg Clin North Am. 2008; 20(3):445–458.

Schreibstein, JM, Tronic, B, Tarlov, E, et al. Benign metastasizing pleomorphic adenoma. Otolaryngol Head Neck Surg. 1995; 112(4):612–615.

Shashinder, S, Tang, IP, Velayutham, P, et al. A review of parotid tumors and their management: a ten-year-experience. Med J Malaysia. 2009; 64(1):31–33.

Speight, PM, Barrett, AW. Salivary gland tumours. Oral Dis. 2002; 8:229–240.

Stanley, MW. Selected problems in fine needle aspiration of head and neck masses. Mod Pathol. 2002; 15(3):342–350.

Valentini, V, Fabiani, F, Perugini, M, et al. Surgical techniques in the treatment of pleomorphic adenoma of the parotid gland: our experience and review of literature. J Craniofac Surg. 2001; 12(6):565–568.

Mucocele and Fibroma*


The current patient was seen in the clinic for excisional biopsy under local anesthesia. Care was taken to evert the lower lip with finger pressure against the skin. This provides increased exposure of the mass on the mucosal surface. A straight-line incision is made perpendicular to the vermillion border over the length of the mass on the mucosal surface. This is followed with careful blunt and sharp dissection around the mucocele and the offending gland. The surgical specimen was labeled and sent to pathology, and a diagnosis of a mucocele was confirmed.

An alternative surgical approach to treatment of a mucocele includes excision or marsupialization with a carbon dioxide laser. Cryotherapy has also been used for the treatment of mucoceles. Direct application of liquid nitrogen is made with a cotton-tip applicator. A major advantage of this technique is compliance in pediatric patients.


Mucoceles, also called mucus retention cysts or mucus extravasation phenomenon, by definition are cavities filled with mucus produced by trauma to minor salivary glands. With functional trauma to the soft tissue and underlying glands, mucus leaks into the adjacent tissues, creating a mucocele. It is the most common lesion affecting the oral mucosa. It can grow to a few millimeters in size and rarely is larger than 1.5 cm. The lower lip is the most common site of a mucocele due to its susceptibility to trauma. Seldom are these lesions seen in the upper lip, even though it has an equivalent number of minor salivary glands. In a recent study of the distribution of mucoceles in 263 patients, 78% occurred in the lower lip and 3% occurred in the upper lip. These findings are consistent with previous studies. Mucoceles do not have an epithelial lining (in contrast to salivary duct cysts). The extravasation of mucus produces a wall of inflamed fibrous tissue.

The oral fibroma (irritational or traumatic) is one of the most common exophytic, soft tissue lesions seen in the oral cavity, with an incidence of 12 lesions per 1,000 population. It is considered a reactive hyperplasia of fibrous connective tissue in response to local irritation or trauma. These lesions have limited growth potential, and the lesion may even decrease in size after prolonged removal of irritation or trauma.

Clinically, the fibroma can occur anywhere in the oral cavity, but it is most common in the buccal mucosa along the occlusal plane. Other common sites are the labial mucosa, tongue, and gingiva. Fibromas often appear pink due the absence of vascularity. Most commonly, they appear as a well-circumscribed nodule that is often pedunculated or sessile. Rarely do the lesions exceed 2 cm in the greatest dimension. In some cases, the lesion can appear white due to hyperkeratosis from continual irritation. Occasionally, the fibroma can appear mildly erythematous and even ulcerated, if recently traumatized. Fibromas most commonly occur between ages 30 and 50 years, favoring females to males in a 2 : 1 ratio in cases submitted for biopsy. Treatment is conservative surgical excision, and the prognosis is excellent, with rare recurrence. It is important to submit the lesion for histopathologic diagnosis, because some benign, and even malignant, tumors can mimic the clinical appearance of the fibroma.

Histologically, the lesion appears as a nodular mass of fibrous connective tissue covered by stratified squamous epithelium; this is consistent with the diagnosis of a traumatic (irritation) fibroma of the buccal mucosa

Occasionally, chronic inflammatory infiltrates can be seen in the connective tissue portion of the lesion.


Bahadure, RN, Fulzele, P, Thosar, N, et al. Conventional surgical treatment of oral mucocele: a series of 23 cases. Eur J Paediatr Dent. 2012; 13(2):143–146.

Baurmash, H. Mucoceles and ranulas. J Oral Maxillofac Surg. 2003; 61:369–378.

Bouquot, JE, Gundlach, KK. Oral exophytic lesions in 23,616 white Americans over 35 years of age. Oral Surg Oral Med Oral Pathol. 1986; 62(3):284–291.

Harrison, JD. Salivary mucoceles. Oral Surg Oral Med Oral Pathol. 1975; 39:268–278.

Ishimaru, M. A simple cryosurgical method for treatment of oral mucous cysts. Int J Oral Maxillofac Surg. 1993; 22:353–355.

Jinbu, Y. Mucocele of the glands of Blandin-Nuhn: clinical and histopathologic analysis of 26 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003; 95:467–470.

Kopp, WK, St-Hilaire, H. Mucosal preservation in the treatment of mucocele with CO2 laser. J Oral Maxillofac Surg. 2004; 62:1559–1561.

Mandel, L, Baurmash, H. Irritation fibroma: report of a case. NY State Dent J. 1970; 36(6):344–347.

Martins-Filho, PR, Santos Tde, S, da Silva, HF, et al. A clinicopathologic review of 138 cases of mucoceles in a pediatric population. Quintessence. 2011; 42(8):679–685.

Marx, RE, Stern, D. Oral and maxillofacial pathology: a rational for diagnosis and treatment. Carol Stream, Ill: Quintessence; 2003.

Neville, BW, Damm, DD, Allen, CM. Oral and maxillofacial pathology, ed 2. Philadelphia: Saunders; 2002.

Regezi, JA, Courtney, RM, Kerr, DA. Fibrous lesions of the skin and mucous membranes which contain stellate and multinucleated cells. Oral Surg Oral Med Oral Pathol. 1975; 39(4):605–614.

Regezi, JA, Sciubba, JJ. Connective tissue lesions. In: Regezi JA, Sciubba JJ, eds. Oral pathology. Philadelphia: Saunders; 1995:191.

Sela, J, Ulmansky, M. Mucous retention cyst of salivary glands. J Oral Surg. 1969; 27(8):619–623.

Acute Herpetic Gingivostomatitis*


The patient’s mother reports that he has been in distress with mouth pain and has not been eating well for the past few days (pain is the most common presenting symptom). The parents noticed multiple vesicles and ulcers in his mouth 2 days earlier. He has had a low-grade temperature over the past 2 days, which they have treated with acetaminophen (in the pediatric population, decreased oral intake is often the first sign of a developing infectious/pathologic process).

It is important to distinguish primary and recurrent infection. Primary infection tends to be more severe and can occur anywhere in the oral cavity. Symptoms typically last 1 week and can be associated with malaise, lymphadenopathy, and fever. Recurrent disease occurs sporadically and tends to be limited to the keratinized mucosa.


General. The patient is an uncooperative, anxious boy in otherwise good health.

Vital signs. His blood pressure is 105/70 mm Hg, heart rate 100 bpm, respirations 18 per minute, and temperature 38.9°C (febrile).

Maxillofacial. He has palpable cervical lymph nodes (this is commonly seen with acute herpetic gingivostomatitis). The face is symmetrical, with no other obvious signs of infection or edema.

Intraoral. Multiple vesicles and ulcerations extend over the buccal and labial alveolar mucosa and dorsal tongue (Figures 7-5) (primary acute herpetic gingivostomatitis can affect both the keratinized and nonkeratinized mucosa, but recurrent infection preferentially involves the keratinized tissue). Ulcerations measure from 1 to 3 mm in diameter and are covered by a pseudomembrane and an erythematous border. The gingiva is erythematous and painful, and there is copious saliva production with drooling. The ulcers present as foul-smelling ulcers when they rupture due to the friable pseudomembrane.

Extremities. Right thumb displays similar erythematous vesicles and ulcerations (consistent with herpetic whitlow).


Acute herpetic gingivostomatitis is a self-limiting condition usually resolving within 3 weeks from the onset of symptoms. Treatment predominantly involves observation and palliative care. This may involve topical anesthetics and over-the-counter pain relief, such as acetaminophen or ibuprofen. Fluids and electrolyte status should be monitored as needed to avoid dehydration.

Pharmacologic treatment is often minimal due to the self-limiting course of the herpes virus. In more severe cases, pharmacotherapy can be of use if administered appropriately. Conventional antiviral therapy (e.g., acyclovir, valacyclovir, and penciclovir) has proved effective and can shorten the healing times by several days.

Primary acute herpetic gingivostomatitis can be managed on an outpatient basis with aggressive oral hydration, analgesia, and topical and systemic antiviral therapy. The main criteria for hospital admission include severe dehydration and pain.

Adult patients are typically managed on an outpatient basis. Severe disease refractory to treatment may indicate an underlying cause of immunosuppression that may require further evaluation for recurrent, persistent, or refractory disease.


The main complications include potential nutritional deficiencies and inadequate fluid intake leading to dehydration, ocular involvement, herpetic whitlow, and central nervous system involvement.

Ocular herpes is relatively rare, affecting 50,000 patients in the United States per year. Stromal keratitis occurs in 25% of patients affected with ocular symptoms, involves inflammation of the deep layers of the cornea, and can lead to globe rupture and blindness. Herpetic whitlow is an intense, painful infection of the hand, involving one or more fingers, that typically affects the terminal phalanx. HSV-1 is the cause in approximately 60% of cases of herpetic whitlow, and HSV-2 is the cause in the remaining 40%. In children, HSV-1 is the most likely causative agent. Infection involving the fingers usually is due to autoinoculation from primary oropharyngeal lesions as a result of finger-sucking or thumb-sucking behavior in patients with herpes labialis or herpetic gingivostomatitis. In the general adult population, herpetic whitlow is most often due to autoinoculation from genital herpes; therefore, it is most frequently secondary to infection with HSV-2. Before the use of gloves, herpetic whitlow was common among dentists, transmitted by the infected oropharyngeal secretions of patients. Transmission easily can be prevented by the use of gloves and by scrupulous observation of universal fluid precautions.

Although a prodrome of fever and malaise may be observed, most often the initial symptoms are pain and burning or tingling of the infected digit. This usually is followed by erythema, edema, and the development of 1- to 3-mm grouped vesicles on an erythematous base over the next 7 to 10 days. These vesicles may ulcerate or rupture and usually contain clear fluid, although the fluid may appear cloudy or bloody. Lymphangitis and epitrochlear and axillary lymphadenopathy are not uncommon. After 10 to 14 days, symptoms usually improve significantly, and lesions crust over and heal.

After the initial infection, the virus enters cutaneous nerve endings and migrates to the peripheral ganglia and Schwann cells, where it lies dormant. They are protected from antibody detection due to the blood-brain barrier and therefore lie dormant in the cell bodies of the gasserian ganglion. The primary infection usually is the most symptomatic. Recurrences observed in 20% to 50% of cases are usually milder and shorter in duration.

More than 2,100 cases of herpetic encephalitis are seen in the United States per year, making it a rare but extremely serious brain disease. HSV-1 is almost always the culprit, except in newborns. In about 70% of infant herpes encephalitis, the disease occurs when a latent HSV-2 virus is activated. Untreated, herpes encephalitis is fatal in more than 70% of cases. Fortunately, rapid diagnostic tests and treatment with acyclovir have significantly improved both survival rates (up to about 80%) and complication rates.


Acute gingivostomatitis is an oral presentation of HSV-1. The virus typically presents in children between the ages of 6 months and 5 years, with a peak incidence at 2 to 3 years of age. Infection is rare before 6 months of age due to the presence of maternal anti-HSV antibodies. Manifestations rarely present into adulthood.

The initial clinical presentation includes fever, nausea, and cervical lymphadenopathy, although it is thought that 90% of all primary infections are subclinical. Patients may proceed to display multiple small, yellow- or white-filled vesicles, which develop into 1- to 3-mm ulcers after a few days and ultimately heal with some scarring. These vesicles and ulcers can present on attached and unattached gingiva and the tongue. Affected gingiva is erythematous, enlarged, and painful, often leading to constitutional symptoms such as dehydration from lack of adequate oral intake. In adults, acute herpetic gingivostomatitis can also present as pharyngotonsillitis. Diagnosis is primarily based on clinical presentations, along with the absence of any previous clinical symptoms and confirmatory laboratory studies.

Aphthous Ulcers*


There is no known history of immunosuppression, HIV, malnutrition, cancer, or previous infections of the head and neck region (potential risk factors).

A careful history may identify contributing etiologic factors. In some individuals, the ulcers are a secondary or hypersensitivity response to an antigenic stimulus, especially foods, whereas in other cases the ulcers represent a primary autoimmune disorder. Patients with aphthae have a decreased ratio of T-helper (CD4+) cells to T-suppressor/cytotoxic (CD8+) cells in their circulation, and the ulcer bed itself has a high level of CD8+ cytotoxic T cells. Although this is a likely contributor to the cellular destruction caused by these ulcers, initiating causes are variable due to multiple contributing factors: familial predisposition, allergy, nutritional imbalances, infectious agents, hormones, trauma, stress, and blood dyscrasias. Individuals with comorbid extraoral diseases, such as Behçet disease (ulcerations of the genitalia and ocular and oral mucous membranes), Crohn’s disease, celiac disease, ulcerative colitis, psoriasis, and ankylosing spondititis are at increased risk of developing aphthous ulcerations. Cyclic neutropenia is responsible for a subgroup of patients with aphthous stomatitis, with the ulcers occurring at points of minor trauma during times when the number of circulating neutrophils is low. Stress may be indirectly responsible for the sores, which were once called “stress ulcers,” through its modulation of the immune system. Paradoxically, tobacco smoking, with its own immune modulation, is often protective, probably because of the increased keratinization resulting from local irritation of the oral mucous membranes.


General. The patient is a well-developed and well-nourished woman in no apparent distress.

Vital signs. Vital signs are stable, and the patient is afebrile (fever is usually not seen with aphthous ulcers).

Maxillofacial. There is no facial swelling or cervical lymphadenopathy.

Intraoral. There are multiple ulcerations at various stages of healing in the oral mucosa measuring 6 to 12 mm. Two ulcers at the right buccal mucosa appear to coalesce. There is also a 7-mm ulcer of the left lateral tongue. The lesions demonstrate a central zone of ulceration covered by a fibrinopurulent membrane that is surrounded by a varying degree of erythema along the margins. There does not appear to be any source of trauma in association with the ulcers (sharp dental restorations or fractured dental cusps). Figures 7-6 and 7-7 show examples of minor and major aphthous ulcers on the mucosa of the commissure and the palate.

Jan 12, 2015 | Posted by in Oral and Maxillofacial Surgery | Comments Off on 7: Head and Neck Pathology
Premium Wordpress Themes by UFO Themes